- NCIt
- C8101
Loading cancer entity…
Loading cancer entity…
Clinical trials
1,164 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00003359 | T138067 Sodium in Treating Patients With Advanced Refractory Cancer | completed | Phase 1 | 24 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 25, 2013 | clinicaltrials |
| NCT00003430 | L-778,123 in Treating Patients With Recurrent or Refractory Solid Tumors | completed | Phase 1 | 40 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 25, 2013 | clinicaltrials |
| NCT00003755 | Ro 31-7453 in Treating Patients With Locally Advanced or Metastatic Solid Tumor | completed | Phase 1 | 40 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 25, 2013 | clinicaltrials |
| NCT00003004 | Combination Chemotherapy in Treating Patients With Refractory or Recurrent Solid Tumors | completed | Phase 1 | 73 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 24, 2013 | clinicaltrials |
| NCT00003242 | Bryostatin 1 Plus Paclitaxel and Cisplatin in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 24, 2013 | clinicaltrials |
| NCT00003630 | Arsenic Trioxide in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 24, 2013 | clinicaltrials |
| NCT00004065 | Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 24, 2013 | clinicaltrials |
| NCT00003742 | Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid Tumors | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 21, 2013 | clinicaltrials |
| NCT00004057 | Paclitaxel Plus L-778,123 in Treating Patients With Recurrent or Refractory Solid Tumors or Lymphomas | completed | Phase 1 | 40 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 21, 2013 | clinicaltrials |
| NCT00004059 | Fluorouracil Plus UCN-01 in Treating Patients With Advanced or Refractory Solid Tumors | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 21, 2013 | clinicaltrials |
| NCT00005634 | Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00006375 | LY293111 in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 18, 2013 | clinicaltrials |
| NCT00014365 | Ro 31-7453 in Treating Patients With Metastatic Solid Tumors | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 18, 2013 | clinicaltrials |
| NCT00016172 | ZD0473 and Doxorubicin in Treating Patients With Advanced Solid Tumors or Lymphoma | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 18, 2013 | clinicaltrials |
| NCT00004016 | Interferon Gamma in Treating Patients With Recurrent or Metastatic Melanoma or Other Solid Tumors | completed | Phase 1 | — | University of RochesterOTHER | 1 | Jun 6, 2013 | clinicaltrials |
| NCT00074321 | Irinotecan, Oxaliplatin, and Capecitabine in Treating Patients With Unresectable Solid Tumors | completed | Phase 1 | 84 | National Cancer Institute (NCI)NIH | 1 | Jun 6, 2013 | clinicaltrials |
| NCT00042900 | Pyroxamide in Treating Patients With Advanced Cancer | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 5, 2013 | clinicaltrials |
| NCT00030368 | Bortezomib and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors | completed | Phase 1 | 45 | National Cancer Institute (NCI)NIH | 1 | Jun 4, 2013 | clinicaltrials |
| NCT00042874 | Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid Tumors | completed | Phase 1 | 77 | National Cancer Institute (NCI)NIH | 1 | Jun 4, 2013 | clinicaltrials |
| NCT00047047 | Tanespimycin, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 78 | National Cancer Institute (NCI)NIH | 1 | Jun 4, 2013 | clinicaltrials |
| NCT00098501 | CCI-779 and EKB-569 in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 42 | National Cancer Institute (NCI)NIH | 1 | Jun 4, 2013 | clinicaltrials |
| NCT00119236 | 17-AAG and Irinotecan in Treating Patients With Locally Advanced or Metastatic Solid Tumors | completed | Phase 1 | 48 | National Cancer Institute (NCI)NIH | 1 | Jun 4, 2013 | clinicaltrials |
| NCT00002587 | Paclitaxel Plus Topotecan in Treating Patients With Solid Tumors | completed | Phase 1 | 20 | National Cancer Institute (NCI)NIH | 1 | Jun 3, 2013 | clinicaltrials |
| NCT00003711 | Combination Chemotherapy in Treating Patients With Metastatic Solid Tumors | completed | Phase 1 | — | San Antonio Cancer InstituteOTHER | 1 | May 30, 2013 | clinicaltrials |
| NCT00004926 | ILX23-7553 in Treating Patients With Solid Tumors That Have Not Responded to Previous Therapy | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | May 30, 2013 | clinicaltrials |
| NCT00045448 | Combination Chemotherapy in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | May 30, 2013 | clinicaltrials |
| NCT00059917 | Polyglutamate Camptothecin in Treating Patients With Advanced Cancer | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | May 30, 2013 | clinicaltrials |
| NCT00659568 | Metformin and Temsirolimus in Treating Patients With Metastatic or Unresectable Solid Tumor or Lymphoma | completed | Phase 1 | 28 | London Health Sciences CentreOTHER | 1 | May 30, 2013 | clinicaltrials |
| NCT00054483 | Bortezomib in Treating Patients With Advanced Cancer and Kidney Dysfunction | completed | Phase 1 | 69 | National Cancer Institute (NCI)NIH | 1 | May 16, 2013 | clinicaltrials |
| NCT00054548 | Combination Chemotherapy Plus Oblimersen in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 55 | National Cancer Institute (NCI)NIH | 1 | May 16, 2013 | clinicaltrials |
| NCT00079014 | 3-AP and Doxorubicin In Treating Patients With Metastatic or Refractory Solid Tumors | completed | Phase 1 | 36 | National Cancer Institute (NCI)NIH | 1 | May 16, 2013 | clinicaltrials |
| NCT00084877 | Irinotecan and 3-AP in Treating Patients With Metastatic or Unresectable Solid Tumors | completed | Phase 1 | 36 | National Cancer Institute (NCI)NIH | 1 | May 16, 2013 | clinicaltrials |
| NCT00550927 | Enzastaurin and Bevacizumab in Treating Patients With Locally Advanced or Metastatic Cancer | completed | Phase 1 | 42 | Eli Lilly and CompanyINDUSTRY | 1 | May 15, 2013 | clinicaltrials |
| NCT00112476 | Temsirolimus and Bryostatin 1 in Treating Patients With Unresectable or Metastatic Solid Tumors | completed | Phase 1 | 24 | National Cancer Institute (NCI)NIH | 1 | May 3, 2013 | clinicaltrials |
| NCT00287833 | Bowman-Birk Inhibitor Concentrate in Preventing Cancer in Healthy Men | completed | Phase 1 | 20 | National Cancer Institute (NCI)NIH | 1 | May 3, 2013 | clinicaltrials |
| NCT00348985 | PXD101 and Bortezomib in Treating Patients With Advanced Solid Tumors or Lymphomas | completed | Phase 1 | 55 | National Cancer Institute (NCI)NIH | 1 | May 3, 2013 | clinicaltrials |
| NCT01118611 | Aurora B/C Kinase Inhibitor GSK1070916A in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 38 | Cancer Research UKOTHER | 1 | May 1, 2013 | clinicaltrials |
| NCT00003425 | Phase I/II Study of Escalating-Dose Melphalan w/Autologous SCS & Amifostine Cytoprotect | completed | Phase 1 / Phase 2 | 25 | University of KentuckyOTHER | 1 | Apr 26, 2013 | clinicaltrials |
| NCT00003403 | GPX-100 in Treating Patients With Solid Tumors | completed | Phase 1 | — | Gem PharmaceuticalsINDUSTRY | 1 | Apr 23, 2013 | clinicaltrials |
| NCT00003109 | Irinotecan Plus Raltitrexed in Treating Patients With Refractory Solid Tumors | completed | Phase 1 | 39 | Fox Chase Cancer CenterOTHER | 1 | Apr 17, 2013 | clinicaltrials |
| NCT00021346 | Carboplatin and Gemcitabine in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 8 | Fox Chase Cancer CenterOTHER | 1 | Apr 17, 2013 | clinicaltrials |
| NCT00003207 | Liposomal Doxorubicin and PSC 833 in Treating Patients With AIDS-Related Kaposi's Sarcoma or Other Advanced Cancers | completed | Phase 1 | 14 | Washington University School of MedicineOTHER | 1 | Apr 12, 2013 | clinicaltrials |
| NCT00089362 | Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Apr 10, 2013 | clinicaltrials |
| NCT00003925 | Combination Chemotherapy In Treating Patients With Advanced Cancer | completed | Phase 1 | 36 | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Apr 8, 2013 | clinicaltrials |
| NCT00253565 | Imatinib Mesylate and Capecitabine in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 25 | Herbert HurwitzOTHER | 1 | Apr 8, 2013 | clinicaltrials |
| NCT00016185 | Flavopiridol and Docetaxel in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Apr 5, 2013 | clinicaltrials |
| NCT00003956 | Combination Chemotherapy in Treating Patients With Advanced Cancer | completed | Phase 1 | 25 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 4, 2013 | clinicaltrials |
| NCT00084643 | GTI-2040, Oxaliplatin, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer or Other Solid Tumors | completed | Phase 1 | 20 | National Cancer Institute (NCI)NIH | 1 | Mar 27, 2013 | clinicaltrials |
| NCT00003406 | Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer | completed | Phase 1 / Phase 2 | 30 | Cancer Treatment Centers of AmericaOTHER | 1 | Mar 26, 2013 | clinicaltrials |
| NCT00003703 | Chemotherapy in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | Jewish General HospitalOTHER | 1 | Mar 26, 2013 | clinicaltrials |
Data updated 24 days agoSource updated Jun 25, 2013source: clinicaltrials